|
⚲
|
| Keyboard |
| Pamukcu Rifat
✚
|
|
|---|---|
| CIK # | 0001929298 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001929298] | |
| 4 | [0001929298] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Aprea Therapeutics Inc | |
| Pamukcu Rifat |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Aprea Therapeutics Inc APRE
Stock Options (Right to Buy) · derivative
|
2025-06-05 | Grant | 4,185 | $0.00 | |
|
Aprea Therapeutics Inc APRE
Common Stock
|
2025-06-05 | Grant | 1,045 | $0.00 | |
|
Aprea Therapeutics Inc APRE
Common Stock
|
2024-06-20 | Grant | 1,045 | $0.00 | |
|
Aprea Therapeutics Inc APRE
Stock Options (Right to Buy) · derivative
|
2024-06-20 | Grant | 4,185 | $0.00 | |
|
Aprea Therapeutics Inc APRE
Stock Options (Right to Buy) · derivative
|
2023-08-23 | Grant | 2,000 | $0.00 | |
|
Aprea Therapeutics Inc APRE
Common Stock
|
2023-08-23 | Grant | 500 | $0.00 | |
|
Aprea Therapeutics Inc APRE
Series A Non-Voting Convertible Preferred Stock · derivative
|
2022-08-23 | Conversion | 27,187 | $0.00 | |
|
Aprea Therapeutics Inc APRE
Series A Non-Voting Convertible Preferred Stock · derivative
|
2022-08-23 | Conversion | 4,928 | $0.00 | |
|
Aprea Therapeutics Inc APRE
Common Stock
|
2022-08-23 | Conversion | 271,870 | $0.00 | |
|
Aprea Therapeutics Inc APRE
Common Stock
|
2022-08-23 | Conversion | 49,280 | $0.00 | |
|
Aprea Therapeutics Inc APRE
Common Stock
|
2022-07-28 | Grant | 5,995 | $0.00 | |
|
Aprea Therapeutics Inc APRE
Stock Option (right to Buy) · derivative
|
2022-07-28 | Grant | 29,575 | $0.00 |